Por favor, use este identificador para citar o enlazar este ítem:
https://hdl.handle.net/10495/44131
Registro completo de metadatos
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Toro Londoño, Miguel Ángel | - |
dc.contributor.author | de Lucio, Héctor | - |
dc.contributor.author | García Marín, Javier | - |
dc.contributor.author | Sánchez Alonso, Patricia | - |
dc.contributor.author | García-Soriano, Juan Carlos | - |
dc.contributor.author | Vaquero, Juan J. | - |
dc.contributor.author | Gago, Federico | - |
dc.contributor.author | Alajarín, Ramón | - |
dc.contributor.author | Jiménez Ruiz, Antonio | - |
dc.date.accessioned | 2024-12-16T16:16:16Z | - |
dc.date.available | 2024-12-16T16:16:16Z | - |
dc.date.issued | 2022 | - |
dc.identifier.citation | de Lucio H, García-Marín J, Sánchez-Alonso P, García-Soriano JC, Toro MÁ, Vaquero JJ, Gago F, Alajarín R, Jiménez-Ruiz A. Pyridazino-pyrrolo-quinoxalinium salts as highly potent and selective leishmanicidal agents targeting trypanothione reductase. Eur J Med Chem. 2022 Jan 5;227:113915. doi: 10.1016/j.ejmech.2021.113915. | spa |
dc.identifier.issn | 0223-5234 | - |
dc.identifier.uri | https://hdl.handle.net/10495/44131 | - |
dc.description.abstract | ABSTRACT: Fifteen pyridazino-pyrrolo-quinoxalinium salts were synthesized and tested for their antiprotozoal activity against Leishmania infantum amastigotes. Eleven of them turned out to be leishmanicidal, with EC50 values in the nanomolar range, and displayed low toxicity against the human THP-1 cell line. Selectivity indices for these compounds range from 10 to more than 1000. Compounds 3b and 3f behave as potent inhibitors of the oxidoreductase activity of the essential enzyme trypanothione disulfide reductase (TryR). Interestingly, binding of 3f is not affected by high trypanothione concentrations, as revealed by the noncompetitive pattern of inhibition observed when tested in the presence of increasing concentrations of this substrate. Furthermore, when analyzed at varying NADPH concentrations, the characteristic pattern of hyperbolic uncompetitive inhibition supports the view that binding of NADPH to TryR is a prerequisite for inhibitor-protein association. Similar to other TryR uncompetitive inhibitors for NADPH, 3f is responsible for TryR-dependent reduction of cytochrome c in a reaction that is typically inhibited by superoxide dismutase. | spa |
dc.format.extent | 13 páginas | spa |
dc.format.mimetype | application/pdf | spa |
dc.language.iso | eng | spa |
dc.publisher | Elsevier | spa |
dc.type.hasversion | info:eu-repo/semantics/publishedVersion | spa |
dc.rights | info:eu-repo/semantics/openAccess | spa |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.5/co/ | * |
dc.title | Pyridazino-pyrrolo-quinoxalinium salts as highly potent and selective leishmanicidal agents targeting trypanothione reductase | spa |
dc.type | info:eu-repo/semantics/article | spa |
dc.publisher.group | Grupo de Parasitología, Universidad de Antioquia | spa |
dc.identifier.doi | 10.1016/j.ejmech.2021.113915 | - |
oaire.version | http://purl.org/coar/version/c_970fb48d4fbd8a85 | spa |
dc.rights.accessrights | http://purl.org/coar/access_right/c_abf2 | spa |
dc.identifier.eissn | 1768-3254 | - |
oaire.citationtitle | European Journal of Medicinal Chemistry | spa |
oaire.citationstartpage | 1 | spa |
oaire.citationendpage | 13 | spa |
oaire.citationvolume | 227 | spa |
dc.rights.creativecommons | https://creativecommons.org/licenses/by-nc-nd/4.0/ | spa |
oaire.fundername | Ministerio de Ciencia, Innovación y Universidades | spa |
oaire.fundername | Comunidad de Madrid | spa |
oaire.fundername | Instituto de Salud Carlos III | spa |
dc.publisher.place | París, Francia | spa |
dc.type.coar | http://purl.org/coar/resource_type/c_2df8fbb1 | spa |
dc.type.redcol | https://purl.org/redcol/resource_type/ART | spa |
dc.type.local | Artículo de investigación | spa |
dc.subject.decs | Antiprotozoarios | - |
dc.subject.decs | Antiprotozoal Agents | - |
dc.subject.decs | Relación Dosis-Respuesta a Droga | - |
dc.subject.decs | Dose-Response Relationship, Drug | - |
dc.subject.decs | Inhibidores Enzimáticos | - |
dc.subject.decs | Enzyme Inhibitors | - |
dc.subject.decs | Leishmania infantum | - |
dc.subject.decs | Estructura Molecular | - |
dc.subject.decs | Molecular Structure | - |
dc.subject.decs | NADH NADPH Oxidorreductasas | - |
dc.subject.decs | NADH, NADPH Oxidoreductases | - |
dc.subject.decs | Pruebas de Sensibilidad Parasitaria | - |
dc.subject.decs | Parasitic Sensitivity Tests | - |
dc.subject.decs | Piridazinas | - |
dc.subject.decs | Pyridazines | - |
dc.subject.decs | Pirroles | - |
dc.subject.decs | Pyrroles | - |
dc.subject.decs | Quinoxalinas | - |
dc.subject.decs | Quinoxalines | - |
dc.subject.decs | Sales (Química) | - |
dc.subject.decs | Salts | - |
dc.subject.decs | Relación Estructura-Actividad | - |
dc.subject.decs | Structure-Activity Relationship | - |
dc.subject.decs | Células THP-1 | - |
dc.subject.decs | THP-1 Cells | - |
oaire.awardtitle | PLATESA2-CM | spa |
oaire.awardtitle | NOVELREN | spa |
oaire.awardtitle | FEDER | spa |
oaire.awardtitle | RETIC REDINREN | spa |
dc.description.researchgroupid | COL0007506 | spa |
oaire.awardnumber | PID2019-104070RB-C22 | spa |
oaire.awardnumber | PCTQ2017-85263-R | spa |
oaire.awardnumber | B2017/BMD-3751 | spa |
oaire.awardnumber | RD16/0009/0015 | spa |
dc.subject.meshuri | https://id.nlm.nih.gov/mesh/D000981 | - |
dc.subject.meshuri | https://id.nlm.nih.gov/mesh/D004305 | - |
dc.subject.meshuri | https://id.nlm.nih.gov/mesh/D004791 | - |
dc.subject.meshuri | https://id.nlm.nih.gov/mesh/D018314 | - |
dc.subject.meshuri | https://id.nlm.nih.gov/mesh/D015394 | - |
dc.subject.meshuri | https://id.nlm.nih.gov/mesh/D009247 | - |
dc.subject.meshuri | https://id.nlm.nih.gov/mesh/D021261 | - |
dc.subject.meshuri | https://id.nlm.nih.gov/mesh/D011724 | - |
dc.subject.meshuri | https://id.nlm.nih.gov/mesh/D011758 | - |
dc.subject.meshuri | https://id.nlm.nih.gov/mesh/D011810 | - |
dc.subject.meshuri | https://id.nlm.nih.gov/mesh/D012492 | - |
dc.subject.meshuri | https://id.nlm.nih.gov/mesh/D013329 | - |
dc.subject.meshuri | https://id.nlm.nih.gov/mesh/D000074084 | - |
dc.relation.ispartofjournalabbrev | Eur. J. Med. Chem. | spa |
oaire.funderidentifier.ror | RoR:05r0vyz12 | - |
oaire.funderidentifier.ror | RoR:040scgh75 | - |
oaire.funderidentifier.ror | RoR:00ca2c886 | - |
Aparece en las colecciones: | Artículos de Revista en Ciencias Médicas |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
ToroMiguel_2022_Pyridazino_Pyrrolo_Quinoxalinium.pdf | Artículo de investigación | 1.08 MB | Adobe PDF | Visualizar/Abrir |
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons